Xilio Therapeutics, Inc.XLONASDAQ
Loading
Year-over-year book value per share growth
Latest
153.66%
↑ 104% vs avg
Percentile
P96
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
75.25%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 153.66% |
| Q3 2025 | -141.18% |
| Q2 2025 | -4.78% |
| Q1 2025 | -47.36% |
| Q4 2024 | -17.67% |
| Q3 2024 | -56.53% |
| Q2 2024 | -17.63% |
| Q1 2024 | -30.93% |
| Q4 2023 | -29.94% |
| Q3 2023 | -22.24% |
| Q2 2023 | -21.07% |
| Q1 2023 | -19.35% |
| Q4 2022 | -16.40% |
| Q3 2022 | -12.47% |
| Q2 2022 | -13.24% |
| Q1 2022 | -34.34% |
| Q4 2021 | 105.18% |
| Q3 2021 | -229.52% |
| Q2 2021 | -21.06% |
| Q1 2021 | 2283.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |